Download | October 23, 2006

Datasheet: CTS - Tablet Content Uniformity Testing System

Source: SOTAX Corporation

The SOTAX CTS (Content Testing System), an automated tablet content uniformity testing system. As a multitasking and automated workstation, the CTS can simultaneously sample process, up to three times faster than comparable systems available in the market with superior handling of tablets, capsules, effervescent tablets, powder, pellets and liquids.

The CTS has a uniquely designed SOTAX sample magazine that can run in a basic version with up to 120 (tube size 16 x 160 mm) or 40 (tube size 32 x 115 mm) samples in an unattended operation/sequence. With the extend version of the sample magazine it is possible to run up 240 samples (tube size 16 x 160 mm) or 80 (tube size 115 mm). This unique design allows greater flexibility for the introduction of a wide sample range.

Features

  • The SOTAX automated Content Testing System is manufactured with high quality, inert materials such as PVDF, stainless steel, teflon, glass and PEEK
  • Efficient cleaning design eliminates carry-over between tests
  • Outstanding accuracy and reproducibility
  • Flexible design concept allowing for customized requirements
  • Unique rotating solvents input station allows the insertion of powder into the solvent without residue
  • Dilution ratios of up to 1:40,000 can be performed
  • Choice of up to 8 different media for a maximum flexibility
  • Easy validation of hardware and software
  • Easy re-injection of fractioned samples into HPLC at any time
  • Homogenizer tool without bearing in contact with solvent
access the Download!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online